GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:12925848
Citation |
During, MJ, Cao, L, Zuzga, DS, Francis, JS, Fitzsimons, HL, Jiao, X, Bland, RJ, Klugmann, M, Banks, WA, Drucker, DJ and Haile, CN (2003) Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med. 9:1173-9 |
---|---|
Abstract |
Glucagon-like peptide-1 (GLP-1) is a gut peptide that, together with its receptor, GLP-1R, is expressed in the brain. Here we show that intracerebroventricular (i.c.v.) GLP-1 and [Ser(2)]exendin(1-9) (HSEGTFTSD; homologous to a conserved domain in the glucagon/GLP-1 family) enhance associative and spatial learning through GLP-1R. [Ser(2)]exendin(1-9), but not GLP-1, is also active when administered peripherally. GLP-1R-deficient mice have a phenotype characterized by a learning deficit that is restored after hippocampal Glp1r gene transfer. In addition, rats overexpressing GLP-1R in the hippocampus show improved learning and memory. GLP-1R-deficient mice also have enhanced seizure severity and neuronal injury after kainate administration, with an intermediate phenotype in heterozygotes and phenotypic correction after Glp1r gene transfer in hippocampal somatic cells. Systemic administration of [Ser(2)]exendin(1-9) in wild-type animals prevents kainate-induced apoptosis of hippocampal neurons. Brain GLP-1R represents a promising new target for both cognitive-enhancing and neuroprotective agents. |
Links |
PubMed Online version:10.1038/nm919 |
Keywords |
Administration, Intranasal; Amino Acid Sequence; Animals; Apoptosis/drug effects; Behavior, Animal/drug effects; Cognition/drug effects; Gene Expression; Gene Transfer Techniques; Glucagon/administration & dosage; Glucagon/pharmacology; Glucagon-Like Peptide 1; Hippocampus/cytology; Hippocampus/drug effects; Hippocampus/physiology; Kainic Acid/adverse effects; Learning/drug effects; Learning/physiology; Male; Mice; Mice, Knockout; Molecular Sequence Data; Neurons/drug effects; Neurons/pathology; Neuroprotective Agents/pharmacology; Peptide Fragments/administration & dosage; Peptide Fragments/pharmacology; Protein Precursors/administration & dosage; Protein Precursors/pharmacology; Rats; Rats, Sprague-Dawley; Receptors, Glucagon/drug effects; Receptors, Glucagon/genetics; Receptors, Glucagon/metabolism; Seizures/chemically induced; Seizures/genetics; Sequence Homology, Amino Acid; Signal Transduction |
edit table |
Significance
Annotations
Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
---|---|---|---|---|---|---|---|---|
edit table |
See also
References
See Help:References for how to manage references in GONUTS.